Skip to content

D&A at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$14.52M+57.2%
NeoGenomics logo
NeoGenomicsNEO
$8.78M-6.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
$2.37M-8.3%
GeneDx Holdings logo
GeneDx HoldingsWGS
$6.81M+19.9%
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
$11.86M+93.3%
Veracyte logo
VeracyteVCYT
$5.43M+1.3%

Segments

By segment

See full
Reportable Segment$3.12M+5.7%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's D&A?
CareDx (CDNA) reported D&A of $3.9M in Q1 2026.
How has CareDx's D&A changed year-over-year?
CareDx's D&A increased by 8.3% year-over-year, from $3.6M to $3.9M.
What is the long-term trend for CareDx's D&A?
Over 4 years (2021 to 2025), CareDx's D&A has grown at a 14.3% compound annual growth rate (CAGR), from $8.8M to $15.02M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.